SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-22-000055
Filing Date
2022-11-09
Accepted
2022-11-09 16:10:22
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abus-20220930.htm   iXBRL 10-Q 1424534
2 EX-31.1 a2022-q310xqex311.htm EX-31.1 10914
3 EX-31.2 a2022-q310xqex312.htm EX-31.2 10932
4 EX-32.1 a2022-q310xqex321.htm EX-32.1 4939
5 EX-32.2 a2022-q310xqex322.htm EX-32.2 4969
11 PIPELINE abus-20220930_g1.jpg GRAPHIC 63310
  Complete submission text file 0001447028-22-000055.txt   6134987

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20220930.xsd EX-101.SCH 40349
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20220930_cal.xml EX-101.CAL 48120
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20220930_def.xml EX-101.DEF 224055
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20220930_lab.xml EX-101.LAB 465298
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20220930_pre.xml EX-101.PRE 313536
53 EXTRACTED XBRL INSTANCE DOCUMENT abus-20220930_htm.xml XML 1006245
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 221372655
SIC: 2834 Pharmaceutical Preparations